Langues

28 June 2018 - Neurolixis Appoints Dr. Ronan Depoortère, PhD, as Director of Pharmacology

Neurolixis Inc. offers a warm welcome to Ronan Depoortere, PhD, as Director of Pharmacoogy.
Dr. Depoortere has gained extensive experience of neuropharmacology in several large and medium-sized pharmaceutical companies where he managed in vivo behavioral studies on CNS drug candidates. His expertise will be valuable as Neurolixis moves forward with development of its drug pipeline targeting Parkinson's disease and Rett syndrome and in characterizing development candidates from the drug discovery program.

See more information concerning Neurolixis' management team here.